These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 11474912)
1. Irritable bowel syndrome: toward a cost-effective management approach. Martin R; Barron JJ; Zacker C Am J Manag Care; 2001 Jul; 7(8 Suppl):S268-75. PubMed ID: 11474912 [TBL] [Abstract][Full Text] [Related]
2. The economic consequences of irritable bowel syndrome: a US employer perspective. Leong SA; Barghout V; Birnbaum HG; Thibeault CE; Ben-Hamadi R; Frech F; Ofman JJ Arch Intern Med; 2003 Apr; 163(8):929-35. PubMed ID: 12719202 [TBL] [Abstract][Full Text] [Related]
3. Costs of care for irritable bowel syndrome patients in a health maintenance organization. Levy RL; Von Korff M; Whitehead WE; Stang P; Saunders K; Jhingran P; Barghout V; Feld AD Am J Gastroenterol; 2001 Nov; 96(11):3122-9. PubMed ID: 11721759 [TBL] [Abstract][Full Text] [Related]
4. Tegaserod treatment for IBS: a model of indirect costs. Smith DG; Barghout V; Kahler KH Am J Manag Care; 2005 Apr; 11(1 Suppl):S43-50. PubMed ID: 15926763 [TBL] [Abstract][Full Text] [Related]
5. The spectrum of irritable bowel syndrome: A clinical review. Gilkin RJ Clin Ther; 2005 Nov; 27(11):1696-709. PubMed ID: 16368443 [TBL] [Abstract][Full Text] [Related]
7. Definition and classification of irritable bowel syndrome: current consensus and controversies. Longstreth GF Gastroenterol Clin North Am; 2005 Jun; 34(2):173-87. PubMed ID: 15862928 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials. Rahimi R; Nikfar S; Abdollahi M Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935 [TBL] [Abstract][Full Text] [Related]
9. Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis. Mein SM; Ladabaum U Aliment Pharmacol Ther; 2004 Jun; 19(11):1199-210. PubMed ID: 15153173 [TBL] [Abstract][Full Text] [Related]
10. The cost of migraine and its treatment. Goldberg LD Am J Manag Care; 2005 Jun; 11(2 Suppl):S62-7. PubMed ID: 16095269 [TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Creed F; Fernandes L; Guthrie E; Palmer S; Ratcliffe J; Read N; Rigby C; Thompson D; Tomenson B; Gastroenterology; 2003 Feb; 124(2):303-17. PubMed ID: 12557136 [TBL] [Abstract][Full Text] [Related]
12. Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study. Brun-Strang C; Dapoigny M; Lafuma A; Wainsten JP; Fagnani F Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1097-103. PubMed ID: 17998835 [TBL] [Abstract][Full Text] [Related]
13. The economic burden of irritable bowel syndrome in Canada. Bentkover JD; Field C; Greene EM; Plourde V; Casciano JP Can J Gastroenterol; 1999 Mar; 13 Suppl A():89A-96A. PubMed ID: 10202215 [TBL] [Abstract][Full Text] [Related]
14. A comparison of office-based physician visits for irritable bowel syndrome and for migraine and asthma. Kozma CM; Barghout V; Slaton T; Frech F; Reeder CE Manag Care Interface; 2002 Sep; 15(9):40-3, 49. PubMed ID: 12244649 [TBL] [Abstract][Full Text] [Related]
15. Irritable bowel syndrome: a management strategy. Thompson WG Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct; 13(3):453-60. PubMed ID: 10580921 [TBL] [Abstract][Full Text] [Related]
18. Economic burden attributable to functional bowel disorders in Iran: a cross-sectional population-based study. Moghimi-Dehkordi B; Vahedi M; Pourhoseingholi MA; Khoshkrood Mansoori B; Safaee A; Habibi M; Pourhoseingholi A; Zali MR J Dig Dis; 2011 Oct; 12(5):384-92. PubMed ID: 21955432 [TBL] [Abstract][Full Text] [Related]
19. Economic burden of irritable bowel syndrome. Proposed strategies to control expenditures. Camilleri M; Williams DE Pharmacoeconomics; 2000 Apr; 17(4):331-8. PubMed ID: 10947488 [TBL] [Abstract][Full Text] [Related]
20. Health care utilization and economic issues in irritable bowel syndrome. Gralnek IM Eur J Surg Suppl; 1998; (583):73-6. PubMed ID: 10027677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]